NRX Pharmaceuticals NRXP
NASDAQ NRXP
$2.85 -0.07 (-2.40%)
At close: Oct 1, 2026 · 4:00 PM EDT

NRX Pharmaceuticals (NRXP) Net Margin (2025 - 2026)

Updated

NRX Pharmaceuticals (NRXP) recorded Net Margin of -1500.45% in Q2 2026, down 1370.45 percentage points from the prior quarter.

Analysis

NRX Pharmaceuticals (NRXP) Net Margin (2025 - 2026) Analysis & Trends

On a TTM basis, NRX Pharmaceuticals' Net Margin came in at -684.82% as of Jun 30, 2026; for FY2025, it came in at -2336.49%.

  • Quarterly Net Margin has ranged from -2433.88% in Q3 2025 to 38.45% in Q4 2025 over the past five years.
  • Per Business Quant, the preceding three quarters came in at -130.00% (Q1 2026), 38.45% (Q4 2025) and -2433.88% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 21.86%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 21.27%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -8.04%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 22.61%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 18.81%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 23.62%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -134.51%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -1.65%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 32.99%
10 NRX Pharmaceuticals 126.02 Mn 77.61 Mn 426,000.00 -1,500.45%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1,500.45%
Mar 31, 2026 -130.00%
Dec 31, 2025 38.45%
Sep 30, 2025 -2,433.88%
API Access

NRX Pharmaceuticals Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=NRXP&period=max&api_key=YOUR_API_KEY